MetaCap

Certara (CERT) vs ZoomInfo Technologies (GTM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

Certara (CERT) has outperformed ZoomInfo Technologies (GTM) over the past year, losing 33.5% versus a loss of 63.2%. Over five years, CERT leads with a -77.2% price change compared with -94.3% for GTM. Certara is the larger company by market cap ($1.41 billion vs $1.13 billion), about 1.2 times the size.

On valuation, ZoomInfo Technologies trades at a lower forward P/E (3.4x vs 23.7x for Certara).

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CERT-33.54%GTM-63.21%
+18%-31%-79%
Oct 8, 20251 yearOct 8, 2026
CERT-74.32%GTM-93.86%
+34%-34%-102%
Oct 4, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CERT versus GTM key metrics
MetricCERTGTM
Share price$9.23$3.89
Market cap$1.41B$1.13B
1-day change+6.77%+1.44%
YTD return-1.93%-62.34%
1-year return-33.54%-63.21%
5-year return-77.17%-94.31%
Forward P/E23.673.44
EPS (TTM)$-0.14$-1.83
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$13.11$12.31
52-week low$4.45$2.54
Distance from 52-week high-29.63%-68.44%
Analyst consensusbuyhold
Avg. price target upside-5.58%+17.89%
Average volume3.10M6.30M
Shares outstanding152.54M291.11M
Employees1,5153,180
SectorTechnologyTechnology
IndustryComputer Software: Prepackaged SoftwareComputer Software: Prepackaged Software

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • CERT has outperformed GTM by 29.7 percentage points over the past year.

About Certara

CERT stock →

Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes.

Technology · Computer Software: Prepackaged Software · 1,515 employees

About ZoomInfo Technologies

GTM stock →

ZoomInfo Technologies Inc., together with its subsidiaries, provides go-to-market intelligence and engagement platform for sales, marketing, operations, and recruiting professionals in the United States and internationally. The company's cloud-based platform provides workflow tools and information on organizations and professionals to help users identify target customers and decision makers, obtain continually updated predictive lead and company scoring, monitor buying signals and other attributes of target companies, craft messages, engage through automated sales tools, and track progress through the deal cycle.

Technology · Computer Software: Prepackaged Software · 3,180 employees

CERT vs GTM FAQ

Which is bigger, Certara or ZoomInfo Technologies?

Certara (CERT) is larger, with a market capitalization of $1.41B compared with $1.13B for ZoomInfo Technologies (GTM).

Which stock has performed better over the past year, CERT or GTM?

CERT returned -33.54% over the past 12 months, compared with -63.21% for GTM (price return, excluding dividends). Past performance does not predict future results.

Are Certara and ZoomInfo Technologies in the same industry?

Yes. Both are classified in the Computer Software: Prepackaged Software industry within the Technology sector.

More comparisons